API, Chemical Development & Analytical Services / Radiolabeling: Seeing Through The Mist

Article

Radiolabeling: Seeing Through The Mist

Is the parent drug as well as its associated metabolites adequately evaluated for safety in preclinical studies?
Dr Sean Kitson from Almac’s Radiolabeling and Biocatalysis Group gives an interpretation.

View Resource

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

You may also be interested in

Article

Development and Scale-Up of 7‑COOH CBD Synthesis, a Key Cannabinoid Metabolite

Article

Preparative Chromatography of Peptides and Other Large Molecules

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Article

Development and Scale-Up of 7‑COOH CBD Synthesis, a Key Cannabinoid Metabolite

Preparative Chromatography of Peptides and Other Large Molecules